科博達(603786.SH):公司首個境外工廠已於10月底在日本投產
格隆匯1月2日丨科博達(603786.SH)披露投資者關係活動記錄表顯示,市場全球化是公司重要發展戰略,公司始終立足全球市場佈局和定位,產品面向全球一流客户市場。隨着國外業務不斷增長,根據客户提出的在國外市場就近設廠並提供生產配套的協作要求,公司正在全球範圍內積極深化與國外客户的緊密關係,加快公司國際化步伐,公司首個境外工廠已於10月底在日本投產。
未來公司將不斷優化全球化生產佈局,通過優勢互補、資源整合、資本合作等方式,加快在歐洲、北美等境外投資佈局,構建更加高效的全球供應鏈體系,進一步提升貼近客户的市場服務能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.